Human genome - Guided identification of memory-modulating drugs

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 46, 2013, Pages

  Papassotiropoulos, Andreas ^a,b,c   Gerhards, Christiane ^a   Heck, Angela ^a,b   Ackermann, Sandra ^a   Aerni, Amanda ^a,b   Schicktanz, Nathalie ^a,b   Auschra, Bianca ^a   Demougin, Philippe ^a,c   Mumme, Eva ^a   Elbert, Thomas ^d   Ertl, Verena ^d   Gschwind, Leo ^a   Hanser, Edveena ^a,c   Huynh, Kim Dung ^a,c   Jessen, Frank ^e   Kolassa, Iris Tatjana ^d,f   Milnik, Annette ^a,g   Paganetti, Paolo ^h   Spalek, Klara ^a   Vogler, Christian ^a,b   Muhs, Andreas ^h   Pfeifer, Andrea ^h   De Quervain, Dominique J F ^a,b   more..

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF KONSTANZ   (Germany)

^e UNIVERSITY OF BONN   (Germany)

^f UNIVERSITY OF ULM   (Germany)

^g OTTO VON GUERICKE UNIVERSITY   (Germany)

^h AC IMMUNE SA   (Switzerland)

Author keywords

Emotional memory; Pharmacology; PTSD

Indexed keywords

APREPITANT; BENZODIAZEPINE; DIPHENHYDRAMINE; ERGOTAMINE; FASORACETAM; FESOTERODINE; HISTAMINE H1 RECEPTOR; INTERLEUKIN 1; MEMANTINE; MIRTAZAPINE; MORPHINE; OLANZAPINE; PLACEBO; VASCULOTROPIN;

ANTIDEPRESSANT ACTIVITY; ARTICLE; AVERSIVE BEHAVIOR; BLOOD BRAIN BARRIER; BODY WEIGHT; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG TARGETING; FEMALE; GENE IDENTIFICATION; GENE INTERACTION; GENE REPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN GENOME; LIGAND BINDING; LONG TERM DEPRESSION; MAJOR CLINICAL STUDY; MALE; MEMORY; MEMORY DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMNOLENCE; VISUAL ANALOG SCALE; WORKING MEMORY;

EMOTIONAL MEMORY; PHARMACOLOGY; PTSD;

ADULT; CROSS-OVER STUDIES; DATA MINING; DIPHENHYDRAMINE; DRUG DISCOVERY; FEMALE; FLUOROMETRY; GENOME, HUMAN; GENOTYPE; HUMANS; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MALE; MEMORY; OLIGONUCLEOTIDES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; STRESS DISORDERS, POST-TRAUMATIC; SURVIVORS; SWITZERLAND; YOUNG ADULT;

EID: 84887491630     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1314478110     Document Type: Article

References (38)

1. Manolio TA (2010) Genomewide association studies and assessment of the risk of disease. N Engl J Med 363(2):166-176.
2. Stranger BE, Stahl EA, Raj T (2011) Progress and promise of genome-wide association studies for human complex trait genetics. Genetics 187(2):367-383.
3. Cichon S, et al.; Psychiatric GWAS Consortium Coordinating Committee (2009) Genomewide association studies: History, rationale, and prospects for psychiatric disorders. Am J Psychiatry 166(5):540-556.
4. Lander ES (2011) Initial impact of the sequencing of the human genome. Nature 470(7333):187-197.
5. Hyman SE (2008) A glimmer of light for neuropsychiatric disorders. Nature 455(7215):890-893.
6. Sanseau P, et al. (2012) Use of genome-wide association studies for drug repositioning. Nat Biotechnol 30(4):317-320.
7. Muglia P (2011) From genes to therapeutic targets for psychiatric disorders - what to expect? Curr Opin Pharmacol 11(5):563-571.
8. Hyman SE (2012) Revolution stalled. Sci Transl Med 4(155): 1-5.
9. Manolio TA, Brooks LD, Collins FS (2008) A HapMap harvest of insights into the genetics of common disease. J Clin Invest 118(5):1590-1605. (Pubitemid 351632361)
10. Wang K, Li M, Hakonarson H (2010) Analysing biological pathways in genome-wide association studies. Nat Rev Genet 11(12):843-854.
11. Voineagu I, et al. (2011) Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474(7351):380-384.
12. Holmans P, et al.; Wellcome Trust Case-Control Consortium (2009) Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet 85(1):13-24.
13. Sklar P, et al.; Psychiatric GWAS Consortium Bipolar Disorder Working Group (2011) Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43(10):977-983.
14. Stergiakouli E, et al.; deCODE Genetics; Psychiatric GWAS Consortium (2012) Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. Am J Psychiatry 169(2):186-194.
15. O'Dushlaine C, et al.; International Schizophrenia Consortium (2011) Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 16(3):286-292.
16. de Quervain DJ, et al. (2012) PKCα is genetically linked to memory capacity in healthy subjects and to risk for posttraumatic stress disorder in genocide survivors. Proc Natl Acad Sci USA 109(22):8746-8751.
17. de Quervain DJ, et al. (2007) A deletion variant of the alpha2b-adrenoceptor is related to emotional memory in Europeans and Africans. Nat Neurosci 10(9):1137-1139.
18. de Quervain DJ, Margraf J (2008) Glucocorticoids for the treatment of post-traumatic stress disorder and phobias: A novel therapeutic approach. Eur J Pharmacol 583(2-3):365-371.
19. McGaugh JL (2003) The Making of Lasting Memory. Memory and Emotion (Weidenfeld and Nicolson, London).
20. Mineka S, Oehlberg K (2008) The relevance of recent developments in classical conditioning to understanding the etiology and maintenance of anxiety disorders. Acta Psychol (Amst) 127(3):567-580.
21. Phelps EA, LeDoux JE (2005) Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 48(2):175-187. (Pubitemid 41476352)
22. Pitman RK (1989) Post-traumatic stress disorder, hormones, and memory. Biol Psychiatry 26(3):221-223.
23. Rasch B, et al. (2009) A genetic variation of the noradrenergic system is related to differential amygdala activation during encoding of emotional memories. Proc Natl Acad Sci USA 106(45):19191-19196.
24. Zhang K, Cui S, Chang S, Zhang L, Wang J (2010) i-GSEA4GWAS: A web server for identification of pathways/gene sets associated with traits by applying an improved gene set enrichment analysis to genome-wide association study. Nucleic Acids Res 38(Web Server issue):W90-W95.
25. Nam D, Kim J, Kim SY, Kim S (2010) GSA-SNP: A general approach for gene set analysis of polymorphisms. Nucleic Acids Res 38(Web Server issue):W749-W754.
26. Kwon JS, Kim J, Nam D, Kim S (2012) Performance comparison of two gene set analysis methods for genome-wide association study results: GSA-SNP vs i-GSEA4GWAS. Genomics Inform 10(2):123-127.
27. Reiner PB, Kamondi A (1994) Mechanisms of antihistamine-induced sedation in the human brain: H1 receptor activation reduces a background leakage potassium current. Neuroscience 59(3):579-588. (Pubitemid 24131513)
28. Curran HV, Pooviboonsuk P, Dalton JA, Lader MH (1998) Differentiating the effects of centrally acting drugs on arousal and memory: An event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology (Berl) 135(1):27-36. (Pubitemid 28055447)
29. Verster JC, et al. (2003) Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood. J Allergy Clin Immunol 111(3):623-627. (Pubitemid 36337888)
30. Kay GG, et al. (1997) Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance. Arch Intern Med 157(20):2350-2356. (Pubitemid 27479334)
31. Turner C, Handford AD, Nicholson AN (2006) Sedation and memory: Studies with a histamine H-1 receptor antagonist. J Psychopharmacol 20(4):506-517. (Pubitemid 43875180)
32. Brignell CM, Rosenthal J, Curran HV (2007) Pharmacological manipulations of arousal and memory for emotional material: Effects of a single dose of methylphenidate or lorazepam. J Psychopharmacol 21(7):673-683. (Pubitemid 47437918)
33. Kamboj SK, Curran HV, Curran HV (2006) Neutral and emotional episodic memory: Global impairment after lorazepam or scopolamine. Psychopharmacology (Berl) 188(4):482-488. (Pubitemid 46758972)
34. Lieberman HR, Waldhauser F, Garfield G, Lynch HJ, Wurtman RJ (1984) Effects of melatonin on human mood and performance. Brain Res 323(2):201-207. (Pubitemid 15219777)
35. Holbrook TL, Galarneau MR, Dye JL, Quinn K, Dougherty AL (2010) Morphine use after combat injury in Iraq and post-traumatic stress disorder. N Engl J Med 362(2):110-117.
36. Stahl EA, et al.; BIRAC Consortium; YEAR Consortium (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 42(6):508-514.
37. Pitman RK (2011) Will reconsolidation blockade offer a novel treatment for post-traumatic stress disorder? Front Behav Neurosci 5:11.
38. Gamache K, Pitman RK, Nader K (2012) Preclinical evaluation of reconsolidation blockade by clonidine as a potential novel treatment for posttraumatic stress disorder. Neuropsychopharmacology 37(13):2789-2796.